Madison, WI, United States of America

Heinrich K Schnoes


 

Average Co-Inventor Count = 3.5

ph-index = 20

Forward Citations = 1,227(Granted Patents)

Forward Citations (Not Self Cited) = 1,073(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • botho of Madison, WI (US) (1994)
  • Madison, WI (US) (1977 - 1999)

Company Filing History:


Years Active: 1977-1999

Loading Chart...
Loading Chart...
Areas of Expertise:
Calcitriol Derivatives
19-Nor-Vitamin D Compounds
Vitamin D2 Compounds
Synthesis of Steroid Compounds
Cell Differentiation Induction
Osteoporosis Treatment
Proliferative Skin Disorders
Cyclohexylidene Compounds
Seco-Sterol Compounds
Retinoic Acid Derivatives
Vitamin D Analog Preparation
Intermediate Synthesis Processes
100 patents (USPTO):Explore Patents

Title: The Enduring Legacy of Inventor Heinrich K Schnoes

Introduction:

Inventor Heinrich K Schnoes, based in Madison, WI (US), continues to inspire the next generation of inventors with his passion for pushing the boundaries of what is possible through innovation. His legacy as a pioneering inventor will undoubtedly endure for years to come.

Latest Patents:

Heinrich K Schnoes, with a remarkable tally of 100 patents to his name, has recently been granted patents for Calcitriol derivatives and their uses. These innovative compounds aim to treat metabolic bone diseases such as osteoporosis and other disease states treatable with vitamin D compounds. By administering modified vitamin D compounds with in vivo hydrolyzable groups at specific carbon positions, he has revolutionized the field of controlled release pharmaceuticals.

Career Highlights:

Throughout his illustrious career, Heinrich K Schnoes has been associated with prestigious organizations such as the Wisconsin Alumni Research Foundation. His strategic approach to innovation and unwavering commitment to excellence have set him apart as a visionary inventor in the field of pharmaceuticals and healthcare.

Collaborations:

Heinrich K Schnoes has collaborated with esteemed colleagues such as Hector Floyd Deluca and Kato L Perlman, further enhancing his reputation as a team player and a leader in collaborative innovation. Together, they have contributed significantly to the development of groundbreaking technologies and medical advancements.

Conclusion:

In conclusion, Heinrich K Schnoes stands as a beacon of inspiration for aspiring inventors, showcasing the transformative power of relentless dedication to innovation. His pioneering work in the realm of pharmaceuticals and controlled release compounds underscores his enduring impact on the field. As we look towards the future, Heinrich K Schnoes' legacy will continue to shape the landscape of invention and innovation for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…